Results
1
1 companies
argenx
Market Cap: €37.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€607.40
7D
3.9%
1Y
10.0%